USFDA conducted an inspection of Strides Pharma Science Limited's flagship manufacturing facility in Bengaluru, India.

1 report, 1 independent Updated Aug 19

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

United States Food and Drug Administration Bengaluru

Keep exploring

Part of

The US Food and Drug Administration conducted a routine cGMP inspection of a facility belonging to OneSource Specialty Pharma Limited. All 1 developments

The entities involved

United States Food and Drug Administration
agency of the US Department of Health and Human Services
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
- FDA inspection at Unichem Laboratories Limited's Goa facility found procedural enhancements needed, leading to market reaction.Sun 10:21
Bengaluru
capital city of Karnataka state in India
- Groww, a company, operates in Indian capital markets and is headquartered in Bengaluru.Mon 16:18
- An AI-led trading platform is serving Indian users, operating out of Bengaluru.Mon 16:18

Coverage

Newest first; wire copies grouped

Aug 19equitybulls.com